FDA Inspection 988719 — Implant Direct Sybron International, LLC

Implant Direct Sybron International, LLC — FEI 3009036368

The FDA completed an inspection of Implant Direct Sybron International, LLC on August 29, 2016 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 29, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Las Vegas, NV (United States)